Literature DB >> 33954875

Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.

Yoshinaga Okugawa1,2, Yuji Toiyama3, Hiroyuki Fujikawa3, Mikio Kawamura3, Hiromi Yasuda3, Takeshi Yokoe3, Ikuyo Mochiki4, Yoshiki Okita3, Masaki Ohi3, Kaname Nakatani4.   

Abstract

PURPOSE: Systemic inflammatory response influences cancer development and perioperative surgical stress can affect the survival of patients with colorectal cancer (CRC). We developed a system to cumulatively assess perioperative inflammatory response and compare the prognostic value of various cumulative inflammatory and nutritional markers in patients with CRC.
METHODS: We assessed perioperative cumulative markers using the trapezoidal area method in 307 patients who underwent surgery for CRC and analyzed the results statistically.
RESULTS: The cumulative lymphocyte to C-reactive protein (CRP) ratio (LCR) predicted survival more accurately than other well-established markers (sensitivity: 80.0%, specificity: 69.3%; area under the curve (AUC): 0.779; P  <  0.001). A low cumulative LCR was correlated with factors associated with disease development, including undifferentiated histology, advanced T stage, lymph node metastasis, distant metastasis, and advanced TNM stage classification. A decreased cumulative LCR was an independent prognostic factor for both overall survival (OS) (Hazard Ratio (HR):5.21, 95% confidence interval [CI] 2.42-11.2; P  <  0.0001) and disease-free survival (DFS) (HR: 1.88, 95% CI 1.07-3.31; P  =  0.02), and its prognostic significance was verified in a different clinical setting. The cumulative LCR was correlated negatively with the intraoperative bleeding volume (P  <  0.0001, R  =  -0.4). Combined analysis of cumulative and preoperative LCR could help stratify risk for the oncological outcomes of CRC patients.
CONCLUSIONS: The findings of this study demonstrate the value of the cumulative LCR in the postoperative management of patients with CRC.
© 2021. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Colorectal cancer; Lymphocyte-C-reactive protein ratio; Perioperative cumulating of systemic inflammation; Prognosis

Mesh:

Substances:

Year:  2021        PMID: 33954875     DOI: 10.1007/s00595-021-02291-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  2 in total

Review 1.  Surgical oncotaxis--excessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients.

Authors:  Toshihiro Hirai; Hideo Matsumoto; Kazuki Yamashita; Atsushi Urakami; Katsumichi Iki; Masahiro Yamamura; Tsukasa Tsunoda
Journal:  Ann Thorac Cardiovasc Surg       Date:  2005-02       Impact factor: 1.520

2.  Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.

Authors:  Shozo Ide; Yuji Toiyama; Yoshinaga Okugawa; Satoshi Oki; Hiromi Yasuda; Hiroyuki Fujikawa; Shigeyuki Yoshiyama; Junitiro Hiro; Minako Kobayashi; Masaki Ohi; Toshimitsu Araki; Masato Kusunoki
Journal:  Anticancer Res       Date:  2017-10       Impact factor: 2.480

  2 in total
  2 in total

1.  Prognostic Role of Lymphocyte-C-Reactive Protein Ratio in Colorectal Cancer: A Systematic Review and Meta Analysis.

Authors:  Xinglong He; Ade Su; Yongcheng Xu; Diaolong Ma; Guoyuan Yang; Yiyun Peng; Jin Guo; Ming Hu; Yuntao Ma
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

2.  Clinical impact of lymphocyte/C-reactive protein ratio on postoperative outcomes in patients with rectal cancer who underwent curative resection.

Authors:  Takehito Yamamoto; Meiki Fukuda; Yoshihisa Okuchi; Yoshiki Oshimo; Yuta Nishikawa; Koji Hisano; Takayuki Kawai; Kohta Iguchi; Yukihiro Okuda; Ryo Kamimura; Eiji Tanaka; Hiroaki Terajima
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.